News: Grifols SA (GRLSbn.MC)

GRLSbn.MC on Madrid SE C.A.T.S.

27.01EUR
24 Oct 2014
Price Change (% chg)

€0.42 (+1.58%)
Prev Close
€26.59
Open
€26.72
Day's High
€27.40
Day's Low
€26.27
Volume
41,434
Avg. Vol
184,907
52-wk High
€34.60
52-wk Low
€21.51

Search Stocks
Select another date:

Thu, Jul 31 2014

REFILE-UPDATE 2-Grifols' half-year profit disappoints, shares fall sharply

* Company says Q2 result hit by one-offs linked to Novartis diagnostics purchase

REFILE-Spain's Grifols H1 adjusted profit up 25 pct, misses fcasts

MADRID, July 31 - Spanish healthcare firm Grifols said first half adjusted net profit rose 25 percent on Thursday, slightly below analysts' expectations in a Reuters poll and boosted by the purchase of a diagnostics business early this year.

Spain's Grifols Q1 net profit grows 33 percent

May 6 - Spanish pharmaceutical company Grifols , the world's third-largest blood products maker, posted a 32.9 percent rise in first-quarter net profit on Tuesday to 121 million euros ($168 million), boosted by its acquisition of Novartis' transfusion diagnostic business.

Select another date:
Search Stocks